China SXT Pharmaceuticals (SXTC) Receivables - Net (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Receivables - Net of $931567.0 for Q1 2026, down 28.41% year-over-year from $1.3 million in Q1 2025, and down 72.18% quarter-over-quarter from $3.3 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Receivables - Net (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Receivables - Net history runs 9 years deep, the most recent figure standing at $931567.0 for Q1 2026.
- In Q1 2026, Receivables - Net fell 28.41% year-over-year to $931567.0; the TTM figure through Mar 2026 stood at $931567.0 (down 28.41% YoY), while the FY2026 annual figure was $2.9 million, down 15.12% from the prior year.
- Receivables - Net for Q1 2026 stood at $931567.0, down from $3.3 million in the prior quarter.
- The five-year high for Receivables - Net was $4.1 million in Q1 2022, with the low at $931567.0 in Q1 2026.
- The 5-year median for Receivables - Net is $3.0 million (2024), against an average of $2.9 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net increased 24.38% in 2024, then sank 57.28% in 2025.
- China SXT Pharmaceuticals' Receivables - Net stood at $4.0 million in 2022, then plunged by 30.8% to $2.8 million in 2023, then rose by 24.38% to $3.4 million in 2024, then fell by 2.83% to $3.3 million in 2025, then tumbled by 72.18% to $931567.0 in 2026.
- Business Quant data shows SXTC's Receivables - Net at $931567.0 in Q1 2026, $3.3 million in Q3 2025, and $1.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | China SXT Pharmaceuticals | 32,992.52 | -28.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 931,567.00 |
| Mar 31, 2026 | 931,567.00 |
| Sep 30, 2025 | 3.35 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.30 Mn |
| Sep 30, 2024 | 3.45 Mn |
| Sep 30, 2024 | 3.45 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 2.87 Mn |
| Mar 31, 2023 | 2.87 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Sep 30, 2022 | 4.00 Mn |
| Mar 31, 2022 | 4.10 Mn |
| Mar 31, 2022 | 4.10 Mn |
| Sep 30, 2021 | 4.16 Mn |
| Sep 30, 2021 | 4.16 Mn |